Walleye Capital’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-100
Closed -$28.7K 4877
2025
Q3
$28.7K Sell
100
-3,200
-97% -$857K ﹤0.01% 4152
2025
Q2
$866K Sell
3,300
-2,400
-42% -$584K ﹤0.01% 2159
2025
Q1
$1.33M Sell
5,700
-5,400
-49% -$1.31M 0.01% 1749
2024
Q4
$2.55M Buy
11,100
+9,900
+825% +$2.27M 0.01% 1563
2024
Q3
$268K Sell
1,200
-11,900
-91% -$2.62M ﹤0.01% 3798
2024
Q2
$2.67M Sell
13,100
-37,000
-74% -$7.53M ﹤0.01% 1841
2024
Q1
$10.9M Buy
50,100
+40,700
+433% +$8.97M 0.02% 779
2023
Q4
$2.14M Buy
9,400
+4,900
+109% +$1.03M ﹤0.01% 1732
2023
Q3
$905K Sell
4,500
-7,024
-61% -$1.48M ﹤0.01% 2325
2023
Q2
$2.39M Buy
+11,524
New +$2.24M 0.01% 1209
2019
Q4
Sell
-2,095
Closed -$302K 2052
2019
Q3
$302K Buy
+2,095
New +$306K 0.02% 978

Other funds holding LH

Walleye Capital's LH Position: Q4 2025 in Review

Walleye Capital sold out of Labcorp (LH) in Q4 2025, closing a stake of 367 shares — an estimated $97.5K sold.

Walleye Capital first reported a position in LH in Q3 2019 and held it in 11 quarters. The position peaked at $13.1M in Q3 2024. 1,024 funds tracked by Wall St. Rank hold LH as of Q4 2025.

  • Walleye Capital reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
  • Walleye Capital sold 367 Labcorp shares in Q4 2025, an estimated $97.5K.
  • Walleye Capital first reported a position in Labcorp in Q3 2019 and held it in 11 quarters.
  • Walleye Capital's Labcorp position peaked at $13.1M in Q3 2024.
  • 1,024 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.